Smoking Cessation Leadership Center's live webinar, What Works: Developing Effective Partnerships to Treat Tobacco Addiction in Behavioral Health Settings will be held on Thu, Sep 23, 2021 2:00 PM EDT. By the end ...
Register for American Lung Association’s Public Health Roadmap: Systems Change Strategies to Address Youth Cessation Webcast on Tuesday, September 28, 2021, at 11 am CST. Tobacco use by adolescents and ...
Nicotine Addiction, Mental Wellbeing & Recovery 101 SCHEDULED AIR DATE: THURSDAY, OCTOBER 21, 12 – 1 P.M. ET Advancement of public health policies and practices over the past 50 years ...
Understanding Motivational Interviewing and SBIRT in Tobacco Cessation Masterclass Workshop Original Air Date: Thursday, October 28, 2–4 p.m. ET Leveraging Screening, Brief Intervention and Referral to Treatment (SBIRT) is an ...
Join APPEAL (Asian Pacific Partners Empowerment, Advocacy, and Leadership) and a panel of experts from the Networking2Save CDC National Networks on Thursday, December 16th at 12 pm ET as we ...
Smoke-free environments in mental health and substance use treatment organizations can reduce tobacco use among these individuals and improve the health of the staff, and yet many mental health and ...
A Conversation Around Addressing Organizational & Leadership Fears and Taking Facilities Tobacco-Free Original Air Date: Friday, January 28, 12:0 p.m. – 1:30 p.m. ET Smoke-free environments in mental health and ...
In the U.S., 34% of adults with mental health challenges who use tobacco identify as Black, and 32% identify as Hispanic/Latinx. Understanding this relationship between mental health and substance use ...
Integrating Racial Equity and Mental Wellbeing in Tobacco Cessation: Tobacco and Mental Wellbeing Masterclass Workshop Original Air Date: February 7th 1:30 - 3:30 pm ET In the U.S., 34% of ...
Description On February 10, 2022, the U.S. Food and Drug Administration's (FDA) Center for Tobacco Products (CTP) is holding a public webinar titled “FDA’s Rulemaking Process and Planned Tobacco Product ...
Varenicline, an FDA-approved prescription smoking cessation aid, is an effective evidence-based treatment for reducing tobacco use among individuals with mental health and substance use challenges. Join the National Behavioral Health ...
National, state, and local-level data sources are essential to address tobacco-related disparities among individuals with mental health and substance use challenges. But, knowing how to find, understand and apply these ...
